Sarcomas of the vagina and uterus

The intergroup rhabdomyosarcoma study

Daniel M. Hays, Hiroyuki Shimada, R. Beverly Raney, Melvin Tefft, William Newton, William M. Crist, Walter Lawrence, Abdel Ragab, Harold Maurice Maurer

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

During a 12-year period (1972-1984), 43 patients with sarcomas of the female genital tract were admitted to the Intergroup Rhabdomyosarcoma Study (IRS), including 31 with primary tumors of the vagina; and 12 with tumors of the uterus, including the cervix. Thirty-four of these can be evaluated on the basis of periods of observation from 18 months to 12 years. Primary tumors of the uterus were a distinct group, distinguished from those arising in the vagina by patient age-range and probably by prognosis, as well as site. Patients with vaginal tumors, with a mean age of 1.8 years, responded to a multimodality approach employing combinations of chemotherapy (vincristine sulfate and actinomycin D, or the aforementioned two drugs with cyclophosphamide ± doxorubicin hydrochloride), irradiation, and/or surgery, with only one tumor-related death, among 24 evaluable patients. In contrast, among the patients with primary uterine tumors, in which the mean age was > 14 years, four of ten evaluable patients died secondary to tumor relapse or progression.

Original languageEnglish (US)
Pages (from-to)718-724
Number of pages7
JournalJournal of Pediatric Surgery
Volume20
Issue number6
DOIs
StatePublished - Jan 1 1985

Fingerprint

Rhabdomyosarcoma
Vagina
Sarcoma
Uterus
Neoplasms
Dactinomycin
Vincristine
Combination Drug Therapy
Cervix Uteri
Doxorubicin
Cyclophosphamide
Observation
Recurrence
Pharmaceutical Preparations

Keywords

  • Sarcoma, vagina
  • rhabdomyosarcoma
  • sarcoma, uterus

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Hays, D. M., Shimada, H., Raney, R. B., Tefft, M., Newton, W., Crist, W. M., ... Maurer, H. M. (1985). Sarcomas of the vagina and uterus: The intergroup rhabdomyosarcoma study. Journal of Pediatric Surgery, 20(6), 718-724. https://doi.org/10.1016/S0022-3468(85)80032-4

Sarcomas of the vagina and uterus : The intergroup rhabdomyosarcoma study. / Hays, Daniel M.; Shimada, Hiroyuki; Raney, R. Beverly; Tefft, Melvin; Newton, William; Crist, William M.; Lawrence, Walter; Ragab, Abdel; Maurer, Harold Maurice.

In: Journal of Pediatric Surgery, Vol. 20, No. 6, 01.01.1985, p. 718-724.

Research output: Contribution to journalArticle

Hays, DM, Shimada, H, Raney, RB, Tefft, M, Newton, W, Crist, WM, Lawrence, W, Ragab, A & Maurer, HM 1985, 'Sarcomas of the vagina and uterus: The intergroup rhabdomyosarcoma study', Journal of Pediatric Surgery, vol. 20, no. 6, pp. 718-724. https://doi.org/10.1016/S0022-3468(85)80032-4
Hays, Daniel M. ; Shimada, Hiroyuki ; Raney, R. Beverly ; Tefft, Melvin ; Newton, William ; Crist, William M. ; Lawrence, Walter ; Ragab, Abdel ; Maurer, Harold Maurice. / Sarcomas of the vagina and uterus : The intergroup rhabdomyosarcoma study. In: Journal of Pediatric Surgery. 1985 ; Vol. 20, No. 6. pp. 718-724.
@article{31fcdb3cffdc48738e16e467b449728a,
title = "Sarcomas of the vagina and uterus: The intergroup rhabdomyosarcoma study",
abstract = "During a 12-year period (1972-1984), 43 patients with sarcomas of the female genital tract were admitted to the Intergroup Rhabdomyosarcoma Study (IRS), including 31 with primary tumors of the vagina; and 12 with tumors of the uterus, including the cervix. Thirty-four of these can be evaluated on the basis of periods of observation from 18 months to 12 years. Primary tumors of the uterus were a distinct group, distinguished from those arising in the vagina by patient age-range and probably by prognosis, as well as site. Patients with vaginal tumors, with a mean age of 1.8 years, responded to a multimodality approach employing combinations of chemotherapy (vincristine sulfate and actinomycin D, or the aforementioned two drugs with cyclophosphamide ± doxorubicin hydrochloride), irradiation, and/or surgery, with only one tumor-related death, among 24 evaluable patients. In contrast, among the patients with primary uterine tumors, in which the mean age was > 14 years, four of ten evaluable patients died secondary to tumor relapse or progression.",
keywords = "Sarcoma, vagina, rhabdomyosarcoma, sarcoma, uterus",
author = "Hays, {Daniel M.} and Hiroyuki Shimada and Raney, {R. Beverly} and Melvin Tefft and William Newton and Crist, {William M.} and Walter Lawrence and Abdel Ragab and Maurer, {Harold Maurice}",
year = "1985",
month = "1",
day = "1",
doi = "10.1016/S0022-3468(85)80032-4",
language = "English (US)",
volume = "20",
pages = "718--724",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Sarcomas of the vagina and uterus

T2 - The intergroup rhabdomyosarcoma study

AU - Hays, Daniel M.

AU - Shimada, Hiroyuki

AU - Raney, R. Beverly

AU - Tefft, Melvin

AU - Newton, William

AU - Crist, William M.

AU - Lawrence, Walter

AU - Ragab, Abdel

AU - Maurer, Harold Maurice

PY - 1985/1/1

Y1 - 1985/1/1

N2 - During a 12-year period (1972-1984), 43 patients with sarcomas of the female genital tract were admitted to the Intergroup Rhabdomyosarcoma Study (IRS), including 31 with primary tumors of the vagina; and 12 with tumors of the uterus, including the cervix. Thirty-four of these can be evaluated on the basis of periods of observation from 18 months to 12 years. Primary tumors of the uterus were a distinct group, distinguished from those arising in the vagina by patient age-range and probably by prognosis, as well as site. Patients with vaginal tumors, with a mean age of 1.8 years, responded to a multimodality approach employing combinations of chemotherapy (vincristine sulfate and actinomycin D, or the aforementioned two drugs with cyclophosphamide ± doxorubicin hydrochloride), irradiation, and/or surgery, with only one tumor-related death, among 24 evaluable patients. In contrast, among the patients with primary uterine tumors, in which the mean age was > 14 years, four of ten evaluable patients died secondary to tumor relapse or progression.

AB - During a 12-year period (1972-1984), 43 patients with sarcomas of the female genital tract were admitted to the Intergroup Rhabdomyosarcoma Study (IRS), including 31 with primary tumors of the vagina; and 12 with tumors of the uterus, including the cervix. Thirty-four of these can be evaluated on the basis of periods of observation from 18 months to 12 years. Primary tumors of the uterus were a distinct group, distinguished from those arising in the vagina by patient age-range and probably by prognosis, as well as site. Patients with vaginal tumors, with a mean age of 1.8 years, responded to a multimodality approach employing combinations of chemotherapy (vincristine sulfate and actinomycin D, or the aforementioned two drugs with cyclophosphamide ± doxorubicin hydrochloride), irradiation, and/or surgery, with only one tumor-related death, among 24 evaluable patients. In contrast, among the patients with primary uterine tumors, in which the mean age was > 14 years, four of ten evaluable patients died secondary to tumor relapse or progression.

KW - Sarcoma, vagina

KW - rhabdomyosarcoma

KW - sarcoma, uterus

UR - http://www.scopus.com/inward/record.url?scp=0022368274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022368274&partnerID=8YFLogxK

U2 - 10.1016/S0022-3468(85)80032-4

DO - 10.1016/S0022-3468(85)80032-4

M3 - Article

VL - 20

SP - 718

EP - 724

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 6

ER -